Publications by authors named "H Lou"

Claim this Profile
T
Targeting the SMAD3/CISD2 axis suppresses bladder cancer progression by promoting ferroptosis in mesenchymal-like bladder cancer cells.
Yulin Sun, Jianghui Wang, Da Gu, Huanmin Lou, Jinpeng Sun

Cell Death Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert insights into the development of large-volume subcutaneous drugs with permeation enhancers: A survey examining challenges, alternatives, and future directions.
Mehul Desai, Srini Tenjarla, Michael Hageman, Hao Lou, Changquan Calvin Sun

Int J Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.
Xiaohua Wu, Jing Wang, Danbo Wang, Guiling Li, Jieqing Zhang, Hanmei Lou

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The METTL3-YTHDC1 axis mediates architectural RNA mA modification to modulate the integrity of chromatin TADs in MLLr + AML genome.
Ruishuang Fu, Wenjuan Yu, Rongjie Zhao, Huimin Yang, Beibei Cao, Hanmei Lou

Mol Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory perylenequinones from the endolichenic fungus Phialocephala fortinii triggered by a histone deacetylase inhibitor.
Ke Xu, Xiao-Bin Li, Yu-Liang Xu, Fei Xie, Hong-Xiang Lou

Fitoterapia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis